Previous 10 | Next 10 |
SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2021 financial and operating results after the market clos...
SAN DIEGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that the European Patent Office has issued a new patent, No. 3352584, to the company...
SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (“TriLink”), a Maravai LifeSciences company (Nasdaq: MRVI) and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, announced today that it expects to suppl...
Maravai LifeSciences Holdings (NASDAQ: MRVI) stock wasn't exactly the picture of health on Friday. It fell by nearly 12%, on news that a group of selling stockholders had priced a big secondary share sale. Maravai announced that those investors are collectively unloading an even...
SAN DIEGO, Calif., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI) , a global provider of life science reagents and services to researchers and biotech innovators, today announced the pricing of a public offering of 20,000,000 shares o...
SAN DIEGO, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI) , a global provider of life science reagents and services to researchers and biotech innovators, today announced the commencement of a public offering of its Class A co...
SAN DIEGO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of September...
Shares of Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) traded today at $60.86, eclipsing its 52-week high. Approximately 102,000 shares have changed hands today, as compared to an average 30-day volume of 979,000 shares. Maravai LifeSciences Holdings Inc is a life sciences company. I...
The following slide deck was published by Maravai LifeSciences Holdings, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Maravai LifeSciences Holdings, Inc. 2021 Q2 - Results - Earnings Call Presentation
Image source: The Motley Fool. Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) Q2 2021 Earnings Call Aug 10, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2021 Earn...
News, Short Squeeze, Breakout and More Instantly...
Maravai LifeSciences Holdings Inc. Company Name:
MRVI Stock Symbol:
NASDAQ Market:
Maravai LifeSciences Holdings Inc. Website:
2024-07-25 20:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on...
- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder assessment to identify and prioritize ESG issues that are most important for Maravai and our stakeholders. - Increased the sc...